Compass Pathways PLC (CMPS)
8.66
+0.13
(+1.52%)
USD |
NASDAQ |
May 06, 12:46
Compass Pathways Price to Book Value: 2.464 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.427 |
| May 02, 2024 | 2.347 |
| May 01, 2024 | 2.413 |
| April 30, 2024 | 2.438 |
| April 29, 2024 | 2.307 |
| April 26, 2024 | 2.259 |
| April 25, 2024 | 2.236 |
| April 24, 2024 | 2.305 |
| April 23, 2024 | 2.347 |
| April 22, 2024 | 2.378 |
| April 19, 2024 | 2.384 |
| April 18, 2024 | 2.396 |
| April 17, 2024 | 2.427 |
| April 16, 2024 | 2.498 |
| April 15, 2024 | 2.367 |
| April 12, 2024 | 2.464 |
| April 11, 2024 | 2.612 |
| April 10, 2024 | 2.609 |
| April 09, 2024 | 2.723 |
| April 08, 2024 | 2.771 |
| April 05, 2024 | 2.703 |
| April 04, 2024 | 2.788 |
| April 03, 2024 | 2.760 |
| April 02, 2024 | 2.689 |
| April 01, 2024 | 2.754 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.367 |
| March 27, 2024 | 2.703 |
| March 26, 2024 | 2.649 |
| March 25, 2024 | 2.609 |
| March 22, 2024 | 2.555 |
| March 21, 2024 | 2.703 |
| March 20, 2024 | 2.783 |
| March 19, 2024 | 2.711 |
| March 18, 2024 | 2.785 |
| March 15, 2024 | 2.817 |
| March 14, 2024 | 2.787 |
| March 13, 2024 | 3.033 |
| March 12, 2024 | 3.06 |
| March 11, 2024 | 3.036 |
| March 08, 2024 | 3.096 |
| March 07, 2024 | 3.209 |
| March 06, 2024 | 3.104 |
| March 05, 2024 | 3.093 |
| March 04, 2024 | 3.272 |
| March 01, 2024 | 3.266 |
| February 29, 2024 | 2.922 |
| February 28, 2024 | 3.519 |
| February 27, 2024 | 3.332 |
| February 26, 2024 | 3.039 |
| February 23, 2024 | 2.899 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.107
Minimum
May 11 2022
10.51
Maximum
Feb 22 2021
3.716
Average
2.703
Median
Mar 21 2024
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 7.215 |
| Biodexa Pharmaceuticals Plc | 0.8094 |
| Verona Pharma PLC | 4.876 |
| NuCana PLC | 0.4404 |
| Autolus Therapeutics PLC | 9.840 |
Price to Book Value Related Metrics
| Price | 8.66 |
| Earnings Yield | -27.31% |
| Market Cap | 556.21M |